Morris Richard Steven has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 85000 shares of Carisma Therapeutics Inc. ($CARM) on June 17, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2024 | Carisma Therapeutics Inc. | $CARM | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Carisma Therapeutics Inc. | $CARM | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 170500 | $0.00 | 170,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Carisma Therapeutics Inc. | $CARM | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 238000 | $0.00 | 238,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Morris Richard Steven | Chief Financial Officer | A | Stock Option (Right to Buy) | 331114 | $0.00 | 331,114.0000 | 0 | 9999.99% | 0.00% |